share_log

FibroGen | 8-K: FibroGen Reports Fourth Quarter and Full Year 2023 Financial Results

SEC announcement ·  Feb 27 05:13
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.